#keepProtocol" /> #keepProtocol" />

Learn how the next billion-dollar acquisition will affect the innovation landscape in the pharmaceutical industry.
Join Gene Quinn, IPWatchdog.com and Marco Richter, LexisNexis PatentSight as they show you how the $74 billion deal between Bristol-Myers Squibb and Celgene may disrupt the crowded market for innovative cancer treatments.


What you will learn in this webinar:

  • how to spot acquisition targets

  • analyzing future scenarios of M&A

  • the impact of advanced patent analytics for due diligence evaluations

  • how to model divestiture scenarios and their effect on the technology landscape

Watch the Recording

Our Offer

Get in touch with us and get an external view on your portfolio. Learn how others see you and survey your market companions from a new perspective.

Get in touch with us